<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02112669</url>
  </required_header>
  <id_info>
    <org_study_id>Laminate CD0006</org_study_id>
    <nct_id>NCT02112669</nct_id>
  </id_info>
  <brief_title>A Multi Center, Study to Evaluate the Safety and Efficacy of the VasQ External Support Device for Arteriovenous Fistulas</brief_title>
  <official_title>A Prospective, Multi Center, Study to Evaluate the Safety and Efficacy of the VasQ External Support Device for Brachiocephalic Arteriovenous Fistula</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laminate Medical Technologies</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Laminate Medical Technologies</source>
  <brief_summary>
    <textblock>
      This study is a prospective, multi center, randomized, controlled study of the VasQ in&#xD;
      arteriovenous fistulas. The VasQ constraints and directs the geometrical parameters of the&#xD;
      fistula as well as the vascular diameter and gradient in the vicinity of the AV shunt. These&#xD;
      geometrical constraints direct flow and influence hemodynamics, and hence minimize turbulence&#xD;
      and promote laminar flow. The device is designed to improve short term maturation and long&#xD;
      term patency of the fistula. The VasQ is a permanent implant intended for use as a&#xD;
      subcutaneous arteriovenous conduit support for vascular access.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2014</start_date>
  <completion_date type="Actual">September 2017</completion_date>
  <primary_completion_date type="Actual">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary safety endpoint: Freedom from severe (i.e. performance of daily activities is compromised) or unanticipated device related adverse events</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary efficacy endpoint: Percentage of AVF physiologically matured</measure>
    <time_frame>3 months</time_frame>
    <description>Successful physiological maturation was defined by a minimum of 5 mm cephalic vein diameter with volume outflow greater than 500 mL/min confirmed by color duplex spectral analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary efficacy endpoint: Primary patency of the study AVF, defined as percentage of patent AVF free from surgical or endovascular interventions</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary efficacy endpoint: Cephalic vein outflow as assess with Doppler ultrasound</measure>
    <time_frame>1, 3, and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary efficacy endpoint: Secondary patency of the study AVF, defined as percentage of patent AVF following surgical or endovascular interventions</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Vascular Access</condition>
  <condition>End Stage Renal Disease</condition>
  <arm_group>
    <arm_group_label>AV fistula with VasQ</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Implant VasQ over AV fistula</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AV fistula</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>AV fistula without any adjunct device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VasQ</intervention_name>
    <arm_group_label>AV fistula with VasQ</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients referred for creation of a new brachiocephalic fistula who consent to take&#xD;
             part in the study.&#xD;
&#xD;
          -  Aged &gt; 18&#xD;
&#xD;
          -  Male and female participants&#xD;
&#xD;
          -  Patients willing and able to attend follow up visits over a period of 6 months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who require revision surgery.&#xD;
&#xD;
          -  Having had previous arteriovenous fistula surgery is not a contraindication to&#xD;
             recruitment provided the new procedure is not revision surgery&#xD;
&#xD;
          -  Target arteries smaller than 3 mm in diameter&#xD;
&#xD;
          -  Target vein smaller than 3 mm in diameter&#xD;
&#xD;
          -  Stenotic veins on the side of surgery as diagnosed on pre-op ultrasound&#xD;
&#xD;
          -  Patients with prior central venous stenosis or obstruction on the side of surgery&#xD;
&#xD;
          -  Depth of vein greater than 8 mm (on US) on side of surgery&#xD;
&#xD;
          -  Known coagulation disorder&#xD;
&#xD;
          -  Prior steal&#xD;
&#xD;
          -  Known allergy to nitinol&#xD;
&#xD;
          -  Life expectancy less than 6 months&#xD;
&#xD;
          -  Inability to give consent and/or comply with the study follow up schedule&#xD;
&#xD;
          -  Women of child bearing age&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Ramat Gan</city>
        <zip>52621</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southmead Hospital</name>
      <address>
        <city>Bristol</city>
        <zip>BS10 5NB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Guy's Hospital</name>
      <address>
        <city>London</city>
        <zip>SE1 9RT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St George's Healthcare</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>April 10, 2014</study_first_submitted>
  <study_first_submitted_qc>April 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 14, 2014</study_first_posted>
  <last_update_submitted>June 4, 2019</last_update_submitted>
  <last_update_submitted_qc>June 4, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Failure, Chronic</mesh_term>
    <mesh_term>Arteriovenous Fistula</mesh_term>
    <mesh_term>Fistula</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

